Sex-Specific Differences in End-of-Life Burdensome Interventions and Antibiotic Therapy in Nursing Home Residents With Advanced Dementia.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
02 08 2019
Historique:
entrez: 17 8 2019
pubmed: 17 8 2019
medline: 17 6 2020
Statut: epublish

Résumé

Nursing home residents with advanced dementia have limited life expectancies yet are commonly subjected to burdensome interventions at the very end of life. Whether sex-specific differences in the receipt of these interventions exist and what levels of physical restraints and antibiotics are used in this terminal setting are unknown. To evaluate the population-based frequency, factors, and sex differences in burdensome interventions and antibiotic therapy among nursing home residents with advanced dementia. This population-based cohort study from Ontario, Canada, used linked administrative databases held at ICES, including the Continuing Care Resident Reporting System Long-Term Care database, which contains data from the Resident Assessment Instrument Minimum Data Set, version 2.0. Nursing home residents (n = 27 243) with advanced dementia who died between June 1, 2010, and March 31, 2015, at 66 years or older were included in the analysis. Initial statistical analysis was completed in May 2017, and analytical revisions were conducted from November 2018 to January 2019. Sex of the nursing home resident. Burdensome interventions (transitions of care, invasive procedures, and physical restraints) and antibiotic therapy in the last 30 days of life. The final cohort included 27 243 nursing home residents with advanced dementia (19 363 [71.1%] women) who died between June 1, 2010, and March 31, 2015, at the median (interquartile range) age of 88 (83-92) years. In the last 30 days of life, burdensome interventions were common, especially among men: 5940 (21.8%) residents were hospitalized (3661 women [18.9%] vs 2279 men [28.9%]; P < .001), 2433 (8.9%) had an emergency department visit (1579 women [8.2%] vs 854 men [10.8%]; P < .001), and 3701 (13.6%) died in an acute care facility (2276 women [11.8%] vs 1425 men [18.1%]; P < .001). Invasive procedures were also common; 2673 residents (9.8%) were attended for life-threatening critical care (1672 women [8.6%] vs 1001 men [12.7%]; P < .001), and 210 (0.8%) received mechanical ventilation (113 women [0.6%] vs 97 men [1.2%]; P < .001). Among the 9844 residents (36.1%) who had a Resident Assessment Instrument Minimum Data Set, version 2.0, completed in the last 30 days of life, 2842 (28.9%) were physically restrained (2002 women [28.3%] vs 840 men [30.4%]; P = .005). More than one-third (9873 [36.2%]) of all residents received an antibiotic (6599 women [34.1%] vs 3264 men [41.4%]; P < .001). In multivariable models, men were more likely to have a transition of care (adjusted odds ratio, 1.41; 95% CI, 1.33-1.49; P < .001) and receive antibiotics (adjusted odds ratio, 1.33; 95% CI, 1.26-1.41; P < .001). Only 3309 residents (12.1%; 2382 women [12.3%] vs 927 men [11.8%]) saw a palliative care physician in the year before death, but those who did experienced greater than 50% lower odds of an end-of-life transition of care (adjusted odds ratio, 0.48; 95% CI, 0.43-0.54); P < .001) and greater than 25% lower odds of receiving antibiotics (adjusted odds ratio, 0.74; 95% CI, 0.68-0.81; P < .001). In this study, many nursing home residents with advanced dementia, especially men, received burdensome interventions and antibiotics in their final days of life. These findings appear to emphasize the need for sex-specific analysis in dementia research as well as the expansion of palliative care and end-of-life antimicrobial stewardship in nursing homes.

Identifiants

pubmed: 31418809
pii: 2748053
doi: 10.1001/jamanetworkopen.2019.9557
pmc: PMC6704739
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e199557

Subventions

Organisme : CIHR
ID : PJT-153060
Pays : Canada
Organisme : NIA NIH HHS
ID : K24 AG033640
Pays : United States

Références

J Gerontol A Biol Sci Med Sci. 1999 Nov;54(11):M546-53
pubmed: 10619316
Infect Control Hosp Epidemiol. 2001 Feb;22(2):120-4
pubmed: 11232875
Int J Geriatr Psychiatry. 2003 Mar;18(3):250-7
pubmed: 12642895
Can J Clin Pharmacol. 2003 Summer;10(2):67-71
pubmed: 12879144
Am J Med Sci. 2004 Jan;327(1):25-32
pubmed: 14722393
Med Care. 2004 Apr;42(4 Suppl):III50-9
pubmed: 15026672
JAMA. 2006 Jun 7;295(21):2503-10
pubmed: 16757722
Ann Intern Med. 2007 Jun 5;146(11):775-86
pubmed: 17548409
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
Arch Intern Med. 2008 Feb 25;168(4):357-62
pubmed: 18299489
CMAJ. 2008 Mar 11;178(6):681-7
pubmed: 18332383
J Am Geriatr Soc. 2008 Dec;56(12):2298-303
pubmed: 19093929
BMC Health Serv Res. 2008 Dec 30;8:277
pubmed: 19115991
N Engl J Med. 2009 Oct 15;361(16):1529-38
pubmed: 19828530
J Am Geriatr Soc. 2010 Mar;58(3):510-7
pubmed: 20398120
Arch Intern Med. 2010 Jul 12;170(13):1102-7
pubmed: 20625013
Dement Geriatr Cogn Disord. 2010;30(2):147-54
pubmed: 20733307
Med Care Res Rev. 2011 Apr;68(2):131-55
pubmed: 20829235
J Am Geriatr Soc. 2010 Dec;58(12):2284-91
pubmed: 21143437
Am J Geriatr Psychiatry. 2011 Sep;19(9):803-13
pubmed: 21873836
J Antimicrob Chemother. 2011 Dec;66(12):2856-63
pubmed: 21954456
N Engl J Med. 2011 Sep 29;365(13):1212-21
pubmed: 21991894
J Am Med Dir Assoc. 2012 Mar;13(3):202-6
pubmed: 22056922
JAMA. 2013 Feb 6;309(5):470-7
pubmed: 23385273
JAMA Intern Med. 2013 Apr 22;173(8):673-82
pubmed: 23552741
J Gen Intern Med. 2013 Nov;28(11):1504-10
pubmed: 23576243
BMJ Support Palliat Care. 2015 Mar;5(1):40-7
pubmed: 24644188
Antimicrob Agents Chemother. 2014 Sep;58(9):5473-7
pubmed: 25001299
JAMA Intern Med. 2014 Oct;174(10):1660-7
pubmed: 25133863
Geriatr Gerontol Int. 2015 Feb;15(2):220-8
pubmed: 25163513
JAMA Intern Med. 2014 Nov;174(11):1763-71
pubmed: 25201279
J Palliat Med. 2015 Jun;18(6):520-6
pubmed: 25927909
J Am Geriatr Soc. 2015 Jun;63(6):1084-90
pubmed: 26031905
N Engl J Med. 2015 Jun 25;372(26):2533-40
pubmed: 26107053
JAMA Intern Med. 2015 Aug;175(8):1331-9
pubmed: 26121537
J Pain Symptom Manage. 2015 Dec;50(6):806-13
pubmed: 26169340
JAMA. 2015 Nov 17;314(19):2017-8
pubmed: 26426830
PLoS Med. 2015 Oct 06;12(10):e1001885
pubmed: 26440803
J Am Med Dir Assoc. 2016 Feb;17(2):155-61
pubmed: 26706418
Lancet Neurol. 2016 Apr;15(5):451-2
pubmed: 26987699
Palliat Med. 2017 Mar;31(3):247-257
pubmed: 27317412
J Alzheimers Dis. 2016 Aug 10;54(1):337-49
pubmed: 27567819
Health Res Policy Syst. 2016 Oct 10;14(1):75
pubmed: 27724961
JAMA. 2016 Nov 8;316(18):1863-1864
pubmed: 27802482
BMJ Open. 2016 Oct 8;6(10):e011912
pubmed: 27855090
Age Ageing. 2017 May 1;46(3):393-400
pubmed: 27916749
Healthc Policy. 2016 Nov;12(2):76-88
pubmed: 28032826
J Am Geriatr Soc. 2017 Jul;65(7):1535-1542
pubmed: 28369696
JAMA Neurol. 2017 Jul 1;74(7):757-758
pubmed: 28492832
J Am Geriatr Soc. 2017 Oct;65(10):2213-2219
pubmed: 28832937
Infect Dis Clin North Am. 2017 Dec;31(4):639-647
pubmed: 29079153
Alzheimers Dement. 2018 Sep;14(9):1101-1103
pubmed: 30196887
J Am Geriatr Soc. 2019 Mar;67(3):609-617
pubmed: 30536383
CMAJ. 2019 Mar 4;191(9):E245-E246
pubmed: 30833490
Am J Psychiatry. 1982 Sep;139(9):1136-9
pubmed: 7114305
J Am Geriatr Soc. 1993 Jan;41(1):25-30
pubmed: 7678104
J Clin Epidemiol. 1994 Nov;47(11):1245-51
pubmed: 7722560
J Gerontol. 1994 Jul;49(4):M174-82
pubmed: 8014392
BMJ. 1997 Oct 25;315(7115):1096-9
pubmed: 9366745

Auteurs

Nathan M Stall (NM)

ICES, Toronto, Ontario, Canada.
Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Division of General Internal Medicine and Geriatrics, Sinai Health System, Toronto, Ontario, Canada.

Hadas D Fischer (HD)

ICES, Toronto, Ontario, Canada.

Kinwah Fung (K)

ICES, Toronto, Ontario, Canada.

Vasily Giannakeas (V)

ICES, Toronto, Ontario, Canada.
Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.

Susan E Bronskill (SE)

ICES, Toronto, Ontario, Canada.
Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.

Peter C Austin (PC)

ICES, Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.

Jeremy N Matlow (JN)

Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Kieran L Quinn (KL)

ICES, Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Division of General Internal Medicine and Geriatrics, Sinai Health System, Toronto, Ontario, Canada.

Susan L Mitchell (SL)

Hebrew SeniorLife Institute for Aging Research, Boston, Massachusetts.

Chaim M Bell (CM)

ICES, Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Division of General Internal Medicine and Geriatrics, Sinai Health System, Toronto, Ontario, Canada.

Paula A Rochon (PA)

ICES, Toronto, Ontario, Canada.
Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH